MOESM2 of Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
Published in 2016 by
Sven Loosen,
Fabian Benz,
Jennifer Niedeggen,
Maximilian Schmeding,
Florian SchĂźller,
Alexander Koch,
Mihael Vucur,
Frank Tacke,
Christian Trautwein,
Christoph Roderburg,
Ulf Neumann,
Tom Luedde
Abstract
Additional file 2: Fig. S1. Serum measurements of S100A6 do not reflect clinical features of CCA such as fatigue (A), pain (B) or an impaired ECOG performance status (C).